tiprankstipranks
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Financial Statements

575 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently ―. The company's EPS TTM is $-1.227; its P/E ratio is -0.07; ENDRA Life Sciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.79M$ -3.10M$ -2.56M$ -2.94M$ -3.29M
EBITDA$ -2.73M$ -3.03M$ -2.48M$ -2.87M$ -3.22M
Net Income Common Stockholders$ -2.78M$ -3.10M$ -2.56M$ -2.94M$ -3.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 4.82M$ 2.36M$ 4.89M
Total Assets$ 5.06M$ 7.60M$ 9.24M$ 6.65M$ 9.27M
Total Debt$ 324.06K$ 434.26K$ 472.65K$ 481.62K$ 546.63K
Net Debt$ 324.06K$ 434.26K$ -4.35M$ -1.87M$ -4.34M
Total Liabilities$ 1.36M$ 2.41M$ 2.31M$ 2.16M$ 2.07M
Stockholders Equity$ 3.70M$ 5.20M$ 6.93M$ 4.50M$ 7.20M
Cash Flow-
Free Cash Flow$ -2.17M$ -2.60M$ -2.27M$ -2.53M$ -3.13M
Operating Cash Flow$ -2.14M$ -2.60M$ -2.27M$ -2.51M$ -3.09M
Investing Cash Flow$ -23.80K--$ -27.00K$ -38.56K
Financing Cash Flow$ 468.90K$ 1.11M$ 4.73M--
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

ENDRA Life Sciences Debt to Assets

ENDRA Life Sciences Cash Flow

ENDRA Life Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis